TOMI Environmental Solutions Announces Partnership with Avantor Expanding Presence of SteraMist Use in Critical Controlled Environments


FREDERICK, Md., Sept. 13, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced expansion of their distribution channels with Avantor® (NYSE: AVTR), a Fortune 500 company and a leading supplier of mission-critical products and services.

This agreement represents a significant milestone for TOMI and highlights a shared commitment to advancing public health and safety. Our partnership is now in the go-to-market phase to ensure a successful market penetration for SteraMist to be a key solution for Avantor’s critical controlled environment customers.

Avantor's vast global network and expertise in procurement provide a significant advantage in reaching a wider customer base, while TOMI's cutting-edge technology complements Avantor's offerings, delivering enhanced value and ensuring optimal cleanliness and microbial reduction to any cleanroom space. The joint marketing efforts will pave the way for accelerated growth for SteraMist under this strengthened collaboration.

Elissa J. (E.J.) Shane, COO of TOMI Environment Solutions, expressed her enthusiasm about the partnership, stating, “Joining forces with Avantor strengthens our commitment to promoting the well-being of businesses and communities safeguarding all critical environments. Avantor's professionalism, reputation, and reach align perfectly with our mission and this collaboration will play a pivotal role in expanding the use of our SteraMist Surface Unit, SteraMist Environment System, and iHP Custom Engineered System in cleanrooms or controlled environments achieving unparalleled cleanliness and disinfection decontamination levels.”

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®  
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology ® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments. 

For additional information, please visit https://steramist.com/ or contact us at info@tomimist.com  

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to our partnership with Avantor. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements involve a number of risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyond our control. As such, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Important factors that could affect our performance and cause results to differ materially from management’s expectations are described in the section entitled “Risk Factors,” in our Annual Report on Form 10-K and other SEC filings. These factors include: our history of losses that may prevent us from achieving profitability in the future; our lack of long-term customer contracts and our inability to rely on our sales history or backlog as an indicator of our future sales; that we are subject to a variety or risks associated with doing business internationally; our success in business depends on our ability to adequately protect our intellectual property; completing of quarter-end financial closing procedure, and that our stock price is volatile and there is a limited market for our shares. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:  

John Nesbett/Rosalyn Christian  

IMS Investor Relations  

tomi@imsinvestorrelations.com